I. Csóka

发表

Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application

G. Balogh, B. Sipos, G. Katona, 2021, Pharmaceutics.

Preliminary study of nanonized lamotrigine containing products for nasal powder formulation

R. Ambrus, G. Katona, Orsolya Jójárt-Laczkovich, 2017, Drug design, development and therapy.

Development of topical nanocarriers for skin cancer treatment using Quality by Design approach.

E. Csányi, M. Budai-Szűcs, I. Csóka, 2018, Current medicinal chemistry.

DEVELOPMENT AND CHARACTERIZATION OF LORATADINE NANOSYSTEMS FOR INTRANASAL DELIVERY USING QUALITY BY DESIGN APPROACH

I. Csóka, Areen Alshweiat, 2020 .

Examination of drug release from hydrogels

I. Erős, E. Csányi, I. Csóka, 2003 .

Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery

B. Sipos, R. Ambrus, G. Katona, 2021, Pharmaceuticals.

Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment.

Edit Benke, R. Ambrus, E. Pallagi, 2020, International journal of biological macromolecules.

Recent insight into strategies for the design of antimicrobial peptides (AMPs)

K. Kristó, I. Csóka, G. Szakonyi, 2022, Acta Pharmaceutica Hungarica.

Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs

I. Csóka, R. Ismail, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Patients’ knowledge on oral anticoagulant treatment in Hungary

I. Csóka, R. Viola, H. Fekete, 2017, International Journal of Clinical Pharmacy.

Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook.

I. Csóka, F. Sabir, R. Ismail, 2020, Drug discovery today.

Analysis of the renewed European Medical Device Regulations in the frame of the non - EU regulatory landscape during the COVID facilitated change.

Orsolya Jójárt-Laczkovich, I. Csóka, SP Yamini Kanti, 2022, Journal of pharmaceutical sciences.

The role of dissolution testing in quality control

I. Erős, I. Csóka, A. Kovács, 2014 .

Development of Solvent-Free Co-Ground Method to Produce Terbinafine Hydrochloride Cyclodextrin Binary Systems; Structural and In Vitro Characterizations

R. Ambrus, Orsolya Jójárt-Laczkovich, Z. Aigner, 2022, Pharmaceutics.

Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives

G. Kozma, Z. Kónya, I. Csóka, 2022, Pharmaceutics.

Optimization of layering technique and secondary structure analysis during the formulation of nanoparticles containing lysozyme by quality by design approach

Ditta Ungor, E. Csapó, K. Kristó, 2021, PloS one.

Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability

G. Katona, M. Deli, Ilona Gróf, 2019, Pharmaceutics.

Formulation of levodopa containing dry powder for nasal delivery applying the quality‐by‐design approach

Masoud Rahimi, R. Ambrus, G. Katona, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration

B. Sipos, G. Katona, L. Janovák, 2020, Pharmaceutics.

Expanding Quality by Design Principles to Support 3D Printed Medical Device Development Following the Renewed Regulatory Framework in Europe

Orsolya Jójárt-Laczkovich, I. Csóka, Livia Adalbert, 2022, Biomedicines.

Development of Thermoresponsive-Gel-Matrix-Embedded Amoxicillin Trihydrate-Loaded Bovine Serum Albumin Nanoparticles for Local Intranasal Therapy

G. Katona, M. Budai-Szűcs, K. Burián, 2022, Gels.

Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts

G. Katona, I. Csóka, Sandra Aulia Mardikasari, 2022, Journal of Drug Delivery Science and Technology.

Cyclodextrin Complexation of Fenofibrate by Co-Grinding Method and Monitoring the Process Using Complementary Analytical Tools

R. Ambrus, Z. Aigner, O. Berkesi, 2022, Pharmaceutics.

Recent Advances in Antimicrobial Coatings and Material Modification Strategies for Preventing Urinary Catheter-Associated Complications

Orsolya Jójárt-Laczkovich, I. Csóka, Livia Adalbert, 2022, Biomedicines.

Optimization and development of stable w/o/w cosmetic multiple emulsions by means of the Quality by Design approach

I. Erős, I. Csóka, A. Kovács, 2016, International journal of cosmetic science.

In vitro and in vivo evaluation of drug release from semisolid dosage forms.

Á. Balogh, I. Csóka, G. Blazsó, 2011, Die Pharmazie.

Comparison of Synthetic Membranes to Heat-Separated Human Epidermis in Skin Permeation Studies In Vitro

E. Csányi, M. Budai-Szűcs, I. Csóka, 2021, Pharmaceutics.

Application of quality by design principles in the development and evaluation of semisolid drug carrier systems for the transdermal delivery of lidocaine

E. Csányi, M. Budai-Szűcs, I. Csóka, 2018 .

Study of the structure of coherent emulsions.

I. Erős, I. Csóka, M. Kónya, 2003, International journal of pharmaceutics.

Investigation of Silicone-Containing Semisolid in Situ Film-Forming Systems Using QbD Tools

E. Csányi, M. Budai-Szűcs, I. Csóka, 2019, Pharmaceutics.

Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method

I Csóka, E. Csányi, I. Csóka, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Spray-dried indomethacin-loaded polymeric micelles for the improvement of intestinal drug release and permeability.

G. Balogh, R. Ambrus, G. Katona, 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

An efficient approach for development and optimisation of curcumin-loaded solid lipid nanoparticles’ patch for transdermal delivery

Nasir M. Ahmad, I. Csóka, N. Ahmed, 2021, Journal of microencapsulation.

Rheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogels

I. Erős, I. Csóka, T. Pénzes, 2004 .

Drug release from semisolid dosage forms: a comparison of two testing methods

G. Baki, I. Erős, I. Csóka, 2015, Pharmaceutical development and technology.

University of Szeged Faculty of Pharmacy Institute of Drug Regulatory Affairs REGULATORY EVALUATION OF DRUG RELEASE FROM DERMAL SEMISOLID DOSAGE FORMS PhD Thesis

Á. Balogh, I. Csóka, G. Blazsó, 2014 .

Erythromycin-loaded polymeric micelles: in situ gel development, in vitro and ex vivo ocular investigations.

G. Katona, M. Budai-Szűcs, K. Burián, 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Evaluation of Ketamine Systemic Absorption from Topical Preparations

G. Zapantis, I. Erős, E. Csányi, 2006, Acta biologica Hungarica.

An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development

E. Pallagi, G. Kozma, Z. Kónya, 2021, Pharmaceutics.

Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer

E. Urbán, Z. Aigner, P. Szabó-Révész, 2018, Drug design, development and therapy.

Study of the microstructure of o/w creams with thermal and rheological methods

S. Rossi, C. Caramella, I. Erős, 2003 .

QbD-Based Investigation of Dermal Semisolid in situ Film-Forming Systems for Local Anaesthesia

E. Csányi, M. Budai-Szűcs, I. Csóka, 2020, Drug design, development and therapy.

Soluplus® promotes efficient transport of meloxicam to the central nervous system via nasal administration.

R. Ambrus, G. Katona, T. Janáky, 2023, International journal of pharmaceutics.

New Approach in Ocular Drug Delivery: In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations

Z. Aigner, J. Lovrić, M. Deli, 2021, Drug design, development and therapy.

DDDT_A_264745 351..360

Z. Aigner, J. Lovrić, M. Deli, 2021 .

Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration

G. Katona, E. Pallagi, Z. Kónya, 2021, Molecules.

Investigation of the effect of polymers on dermal foam properties using the QbD approach.

E. Csányi, M. Budai-Szűcs, I. Csóka, 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Application of the QbD-based approach in the early development of liposomes for nasal administration.

Edina Pallagi, Piroska Szabó-Révész, Ildikó Csóka, 2019, International journal of pharmaceutics.

Optimization of the Critical Parameters of the Spherical Agglomeration Crystallization Method by the Application of the Quality by Design Approach

Z. Aigner, I. Csóka, A. Kovács, 2018, Materials.

EXAMINATION OF THE STRUCTURAL AND PERMEABILITY PROPERTIES OF LIPOSOMES STABILIZED BY NEUTRAL POLYMERS

I. Erős, I. Csóka, Ph.D. Thesis, 2019 .

Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease.

I. Csóka, R. Ismail, H. Akel, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

PEGYLATION AND FORMULATION STRATEGY OF ANTI-MICROBIAL PEPTIDE (AMP) ACCORDING TO THE QUALITY BY DESIGN APPROACH.

Edina Pallagi, Ildikó Csóka, Reihaneh Manteghi, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

University of Szeged

I. Csóka, 2020 .

Preparation and investigation of core-shell nanoparticles containing human interferon-α.

I. Dékány, Á. Márki, A. Kelemen, 2019, International journal of pharmaceutics.

Predicting Drug Release Rate of Implantable Matrices and Better Understanding of the Underlying Mechanisms through Experimental Design and Artificial Neural Network-Based Modelling

I. Ilič, S. Srčič, G. Regdon, 2022, Pharmaceutics.

Optimization of layering technique and the secondary structure analysis during formulation of nanoparticles containing lysozyme by Quality by Design approach

K. Kristó, I. Csóka, Reihaneh Manteghi, 2022, IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science.

Strategies for development of antimicrobial peptides and proteins

K. Kristó, I. Csóka, G. Szakonyi, 2021 .

PEGylation and formulation strategies of antimicrobial peptides and proteins development

K. Kristó, I. Csóka, G. Szakonyi, 2020 .

PEGylation and formulation strategies of antimicrobial peptides and proteins development

I. Csóka, G. Szakonyi, Reihaneh Manteghi, 2020 .

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach

R. Ambrus, E. Pallagi, P. Szabó-Révész, 2016, Drug design, development and therapy.

Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary

E. Berényi, B. Merkely, B. Vásárhelyi, 2020, GeroScience.

Influence of preparation conditions on the properties of Eudragit microspheres produced by a double emulsion method

S. Srčič, K. Pintye-Hódi, I. Erős, 2005 .

Pulmonary drug delivery: Role of antibiotic formulations for treatment of respiratory tract infections

R. Ambrus, I. Csóka, Mahwash Mukhtar, 2019 .

Evaluation of osteoarthritis knee and hip quality of life (OAKHQoL): adaptation and validation of the questionnaire in the Hungarian population

F. Guillemin, E. Pallagi, C. Varjú, 2020, Therapeutic advances in musculoskeletal disease.

Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development

E Pallagi, R Ismail, T L Paál, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach

E. Pallagi, G. Kozma, Z. Kónya, 2022, Molecules.

Exogenic production of bioactive filamentous biopolymer by monogonant rotifers.

J. Kálmán, I. Csóka, É. Ács, 2021, Ecotoxicology and environmental safety.

A comparison study of Lipid and Polymeric Nanoparticles in the Nasal Delivery of Meloxicam: Formulation, Characterization, and In-Vitro Evaluation.

R. Ambrus, G. Katona, I. Csóka, 2021, International journal of pharmaceutics.

Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration

G. Katona, I. Zupkó, I. Csóka, 2022, Pharmaceutics.

Patient expectations and regulatory needs in the risk-based drug development of cystic fibrosis

E. Pallagi, I. Csóka, 2021 .

Stability of multiple emulsions. I. Determination of factors influencing multiple drop breakdown

I. Erős, I. Csóka, 1997 .

Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery

R. Ambrus, G. Katona, I. Csóka, 2019, Pharmaceutical Research.

Optimizing the Crystal Habit of Glycine by Using an Additive for Impinging Jet Crystallization

J. Ulrich, R. Ambrus, Z. Aigner, 2017 .

Design and characterization of loratadine nanosuspension prepared by ultrasonic‐assisted precipitation

Rita Ambrus, Ildikó Csóka, R. Ambrus, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

QbD BASED CONTROL STRATEGY OF LORATADINE NANOSUSPENSIONS AND DRY NANOPARTICLES STABILIZED BY SOLUPLUS®

R. Ambrus, G. Katona, I. Csóka, 2019, FARMACIA.

Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.

Edina Pallagi, Rita Ambrus, Piroska Szabó-Révész, 2015, International journal of pharmaceutics.

Structural analysis of w/o/w multiple emulsions by means of DSC

I. Erős, E. Csányi, I. Csóka, 2005 .

Coherent emulsions containing alkylpolyglucoside esters as emulsifiers

I. Erős, E. Csányi, I. Csóka, 2004 .

Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam

R. Ambrus, P. Szabó-Révész, I. Csóka, 2022, Pharmaceutics.

Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery.

A. Bernkop‐Schnürch, Flavia Laffleur, I. Csóka, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Effects of the controlled temperature in the production of high-shear granulated protein-containing granules

B. Penke, D. Sebők, Á. Kukovecz, 2021, Powder Technology.

A Systematic, Knowledge Space-Based Proposal on Quality by Design-Driven Polymeric Micelle Development

B. Sipos, G. Katona, I. Csóka, 2021, Pharmaceutics.

Development of Dexamethasone-loaded mixed polymeric micelles for nasal delivery.

G. Balogh, B. Sipos, G. Katona, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Mucoadhesive meloxicam-loaded nanoemulsions: development, characterization and nasal applicability studies.

G. Katona, P. Szabó-Révész, I. Zupkó, 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

DEVELOPMENT OF DRY POWDER INHALATION SYSTEMS USING CIPROFLOXACIN HYDROCHLORIDE: NEW ASPECTS OF FORMULATION BY MEANS OF QUALITY BY DESIGN APPROACH

I. Csóka, Habil Ildikó Csóka, 2019 .

Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach

G. Balogh, R. Ambrus, G. Katona, 2020, Pharmaceutics.

Investigation of physicochemical characteristics and tablettability of titanate nanotube-active drug composites

I. Csóka, B. Sipos, 2019 .

Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance.

R. Ambrus, I. Csóka, Heba Banat, 2023, International journal of pharmaceutics.

Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride

R. Ambrus, G. Katona, I. Csóka, 2018, Journal of Pharmaceutical and Biomedical Analysis.

Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes.

Edina Pallagi, Ildikó Csóka, Tamás L Paál, 2018, Drug discovery today.

New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach.

Edina Pallagi, Keyhaneh Karimi, Rita Ambrus, 2016, International journal of pharmaceutics.

Patient adherence and factors influencing quality of life in the case of osteoarthritic patients

E. Pallagi, I. Csóka, R. Fekete, 2020 .

Selected papers of the "12th Central European Symposium on Pharmaceutical Technology and Regulatory Affairs".

R. Dreu, G. Regdon, I. Csóka, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin

R. Ambrus, G. Katona, G. Kozma, 2021, International journal of molecular sciences.

Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading

G. Katona, I. Csóka, Bence Sipos, 2022, Pharmaceutics.

Thermoanalytical investigation of lyotropic liquid crystals and microemulsions for pharmaceutical use

Ildikó Csóka, I. Erős, E. Csányi, 2005 .

A Proposed Methodology for a Risk Assessment-Based Liposome Development Process

Edina Pallagi, Ildikó Csóka, Zsófia Németh, 2020, Pharmaceutics.

Formulation and In Vitro Comparison Study between Lipid-Based and Polymeric-Based Nanoparticles for Nose-to-Brain Delivery of a Model Drug for Alzheimer’s Disease

I. Csóka, H. Akel, 2020 .

Regulatory considerations, challenges and risk-based approach in nanomedicine development.

Orsolya Jójárt-Laczkovich, E. Pallagi, I. Csóka, 2021, Current medicinal chemistry.